Guttman-Yassky, E. ., S. . Weidinger, E. . Simpson, M. . Gooderham, A. . Irvine, L. . Spelman, J. . Silverberg, H. . Elmaraghy, L. . DeLuca-Carter, M. L. . Buziqui Piruzeli, C. . Hu, F. E. . Yang, E. . Pierce, L. . Bardolet, and D. . Thaci. “Efficacy and Safety of Lebrikizumab Is Maintained to Two Years in Patients With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s271, doi:10.25251/skin.7.supp.271.